Comparison of broad-spectrum anti-Pseudomonal beta-lactam antibiotics versus targeted therapy for neutropenic patients with methicillin-susceptible

Authors

• Lauren C Russell, Barnes-Jewish Hospital Department of Pharmacy
• Jeff Klaus, Barnes-Jewish Hospital Department of Pharmacy
• Miguel A Chavez, Washington University School of Medicine in St. Louis
• Erik R Dubberke, Washington University School of Medicine in St. Louis
• Tamara Krekel, Barnes-Jewish Hospital Department of Pharmacy

Journal

Antimicrobial Stewardship & Healthcare Epidemiology

Publication Date

5-13-2025

Volume

5

Issue

1

First Page

e108

Document Type

Open Access Publication

DOI

doi: 10.1017/ash.2025.179

Rights and Permissions

Russell LC, Klaus J, Chavez MA, Dubberke ER, Krekel T. Comparison of broad-spectrum anti-Pseudomonal beta-lactam antibiotics versus targeted therapy for neutropenic patients with methicillin-susceptible Staphylococcus aureus bloodstream infections. Antimicrob Steward Healthc Epidemiol. 2025 May 13;5(1):e108. doi: 10.1017/ash.2025.179 © The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America. This is an Open Access article, distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.

Recommended Citation

Russell, Lauren C; Klaus, Jeff; Chavez, Miguel A; Dubberke, Erik R; and Krekel, Tamara, "Comparison of broad-spectrum anti-Pseudomonal beta-lactam antibiotics versus targeted therapy for neutropenic patients with methicillin-susceptible." Antimicrobial Stewardship & Healthcare Epidemiology. 5, 1. e108 (2025).
https://digitalcommons.wustl.edu/oa_4/7078

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.